Results 251 to 260 of about 3,169,653 (411)

Interleukin-1-receptor antagonist in the Muckle-Wells syndrome [PDF]

, 2003
Hawkins, PN, Lachmann, HJ, McDermott, MF
core   +1 more source

Understanding and measuring mechanical signals in the tumor stroma

FEBS Open Bio, EarlyView.
This review discusses cancer‐associated fibroblast subtypes and their functions, particularly in relation to extracellular matrix production, as well as the development of 3D models to study tumor stroma mechanics in vitro. Several quantitative techniques to measure tissue mechanical properties are also described, to emphasize the diagnostic and ...
Fàtima de la Jara Ortiz, Chiara Cimmino, Maurizio Ventre, Alessandra Cambi   +3 more
wiley   +1 more source

Protection by histamine receptor antagonists and prostaglandin against gastric mucosal barrier disruption in the rat.

, 1979
Gilles Bommelaer, Paul H. Guth
openalex  

Deficiency of Interleukin‐1 Receptor Antagonist Responsive to Anakinra

Pediatric dermatology, 2013
Charlotte Schnellbacher, Giovanna Ciocca, R. Menendez, I. Aksentijevich, R. Goldbach-Mansky, A. Duarte, R. Rivas-Chacon   +6 more
semanticscholar   +1 more source

Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions

FEBS Open Bio, EarlyView.
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik, Deniz Bakkalci, Alexander J. MacRobert, Umber Cheema   +3 more
wiley   +1 more source

Transfer of the Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix Into Breast Milk of Healthy Lactating Women. [PDF]

Pharmacol Res Perspect
Brimhall DB, Chen YL, Lee S, Yoshida K, Ufer M.   +4 more
europepmc   +1 more source

Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.

, 1989
Paolo Golino, J H Ashton, J McNatt, Pia Glas-Greenwalt, S K Yao, R A O'Brien, L. Maximilian Buja, J. T. Willerson   +7 more
openalex   +1 more source

Concentration‐effect relationships with FM 24: a new long acting beta‐ adrenergic receptor antagonist. [PDF]

, 1983
C. T. Dollery, H. J. Dargie, J Sassard, G. Cuisinaud   +3 more
openalex   +1 more source

Comparative single‐cell transcriptomic profiling of patient‐derived renal carcinoma cells in cellular and animal models of kidney cancer

FEBS Open Bio, EarlyView.
We generated and characterized clear cell renal cell carcinoma models using the patient‐derived RCC243 cell line—including cell culture, orthotopic, and metastatic tumors—via single‐cell RNA‐sequencing for comparisons between models and patient tumor datasets.
Richard Huang, Lynn Kee, Alexander Gont, Jalna Meens, Fraser G. Ferens, Meredith S. Irwin, Laurie Ailles, Scott A. Yuzwa, Claire M. Robinson, Michael Ohh   +9 more
wiley   +1 more source

The efficacy and safety of mirabegron and α-adrenergic receptor antagonist in the treatment of distal ureteral stones: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Guo Y, Sun F, Wang Y, Li Y, Wang T, Ma X, Wu J.   +6 more
europepmc   +1 more source